Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic therapy: clinical applications.

William F Baker1

  • 1Center for Health Sciences, University of California Los Angeles, Los Angeles, CA, USA. wbaker@thrombosiscenter.com

Hematology/Oncology Clinics of North America
|March 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Destructive Giant Cell Tumor of the Capitate: A Unique Case of Carpal Reconstruction.

Hand (New York, N.Y.)·2026
Same author

An Isolated Midsubstance ACL Tear Repaired With the BEAR System.

Video journal of sports medicine·2025
Same author

Tramadol-based multimodal pain protocols after arthroscopic rotator cuff repair are similarly effective as oxycodone-based protocols with fewer morphine milligram equivalents prescribed and lower risk of refills.

Journal of orthopaedics·2025
Same author

Does central sensitization correlate with two-year postoperative functional outcome scores following hip arthroscopy?

Journal of orthopaedics·2023
Same author

Use of Telemedicine Among Hand Surgeons and Their Patients.

The Journal of hand surgery·2023
Same author

Stability of trusses by graphic statics.

Royal Society open science·2021

Thrombolytic agents effectively treat blood clots by increasing plasmin production. Combining thrombolytics with angioplasty, stenting, or other agents improves outcomes for arterial and venous thrombosis.

Area of Science:

  • Cardiovascular Medicine
  • Hematology

Background:

  • Understanding thrombosis and fibrinolysis is key to developing effective thrombolytic therapies.
  • Plasminogen activators enhance plasmin production, proving beneficial for arterial and venous thrombotic disorders.

Purpose of the Study:

  • To define the characteristics of an ideal thrombolytic agent for rapid vessel opening without reocclusion or hemorrhage.
  • To review the efficacy of adjunctive therapies and interventional procedures in thrombolytic treatment.

Main Methods:

  • Review of clinical studies on thrombolytic agents and adjunctive therapies.
  • Evaluation of the impact of intravascular angioplasty and stenting on thrombolysis outcomes.

Main Results:

  • Available thrombolytics show efficacy, but an ideal agent remains elusive.

Related Experiment Videos

  • Adjunctive agents enhance thrombolytic benefits without significant added risk.
  • Angioplasty and stenting increase long-term benefits of thrombolysis.

    • Conclusions:

    • Newer thrombolytic agents and protocols hold promise for treating thrombotic events.
    • Combined approaches, including adjunctive therapies and interventions, improve patient outcomes in thrombosis treatment.